• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

中性粒细胞与淋巴细胞比值可作为重症 COVID-19 患者中中重度 ARDS 的预测生物标志物。

Neutrophil-to-lymphocyte ratio as a predictive biomarker for moderate-severe ARDS in severe COVID-19 patients.

机构信息

Department of Critical Care Medicine, West China Hospital of Sichuan University, No. 37, Guoxue Alley, Chengdu, 610041, Sichuan Province, China.

出版信息

Crit Care. 2020 Jun 5;24(1):288. doi: 10.1186/s13054-020-03007-0.

DOI:10.1186/s13054-020-03007-0
PMID:32503668
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7273815/
Abstract

ChiCTR, ChiCTR2000029758. Registered 12 February 2020 - Retrospectively registered.

摘要

ChiCTR，ChiCTR2000029758. 2020 年 2 月 12 日注册-回顾性注册。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/188a/7275421/f64619e9c78c/13054_2020_3007_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/188a/7275421/f64619e9c78c/13054_2020_3007_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/188a/7275421/f64619e9c78c/13054_2020_3007_Fig1_HTML.jpg

相似文献

1
Neutrophil-to-lymphocyte ratio as a predictive biomarker for moderate-severe ARDS in severe COVID-19 patients.中性粒细胞与淋巴细胞比值可作为重症 COVID-19 患者中中重度 ARDS 的预测生物标志物。
Crit Care. 2020 Jun 5;24(1):288. doi: 10.1186/s13054-020-03007-0.
2
Dynamic changes of D-dimer and neutrophil-lymphocyte count ratio as prognostic biomarkers in COVID-19.新冠肺炎患者 D-二聚体和中性粒细胞-淋巴细胞比值的动态变化作为预后生物标志物。
Respir Res. 2020 Jul 3;21(1):169. doi: 10.1186/s12931-020-01428-7.
3
The clinical implication of dynamic neutrophil to lymphocyte ratio and D-dimer in COVID-19: A retrospective study in Suzhou China.新冠肺炎患者中性粒细胞与淋巴细胞比值和 D-二聚体的临床意义：中国苏州的一项回顾性研究。
Thromb Res. 2020 Aug;192:3-8. doi: 10.1016/j.thromres.2020.05.006. Epub 2020 May 6.
4
Diagnostic value of peripheral hematologic markers for coronavirus disease 2019 (COVID-19): A multicenter, cross-sectional study.外周血标志物对 2019 年冠状病毒病（COVID-19）的诊断价值：一项多中心、横断面研究。
J Clin Lab Anal. 2020 Oct;34(10):e23475. doi: 10.1002/jcla.23475. Epub 2020 Jul 17.
5
Clinical and Immune Features of Hospitalized Pediatric Patients With Coronavirus Disease 2019 (COVID-19) in Wuhan, China.中国武汉 2019 年冠状病毒病（COVID-19）住院儿科患者的临床和免疫特征。
JAMA Netw Open. 2020 Jun 1;3(6):e2010895. doi: 10.1001/jamanetworkopen.2020.10895.
6
Incidence of ARDS and outcomes in hospitalized patients with COVID-19: a global literature survey.新型冠状病毒肺炎住院患者中急性呼吸窘迫综合征的发病率及预后：一项全球文献综述
Crit Care. 2020 Aug 21;24(1):516. doi: 10.1186/s13054-020-03240-7.
7
Predictive value of neutrophil to lymphocyte and platelet to lymphocyte ratio in COVID-19.中性粒细胞与淋巴细胞比值及血小板与淋巴细胞比值在新型冠状病毒肺炎中的预测价值
Crit Care. 2020 Aug 28;24(1):532. doi: 10.1186/s13054-020-03258-x.
8
The Characteristics of 50 Hospitalized COVID-19 Patients With and Without ARDS.50 例 COVID-19 住院患者合并与不合并 ARDS 的特征。
Dtsch Arztebl Int. 2020 Apr 17;117(16):271-278. doi: 10.3238/arztebl.2020.0271.
9
Vitamin C levels in patients with SARS-CoV-2-associated acute respiratory distress syndrome.新型冠状病毒肺炎相关急性呼吸窘迫综合征患者的维生素C水平
Crit Care. 2020 Aug 26;24(1):522. doi: 10.1186/s13054-020-03249-y.
10
Comparison of the Clinical Course of COVID-19 Pneumonia and Acute Respiratory Distress Syndrome in 2 Passengers from the Cruise Ship Diamond Princess in February 2020.2020年2月钻石公主号邮轮上两名乘客的新型冠状病毒肺炎与急性呼吸窘迫综合征临床病程比较
Am J Case Rep. 2020 Aug 19;21:e926835. doi: 10.12659/AJCR.926835.

引用本文的文献

1
Immune responses to SARS-CoV-2 infection in Humans and ACE2 humanized mice.人类和ACE2人源化小鼠对SARS-CoV-2感染的免疫反应。
Fundam Res. 2021 Mar;1(2):124-130. doi: 10.1016/j.fmre.2021.03.001. Epub 2021 Mar 3.
2
Age influences blood cell-based immune deregulation antibody response and unfavorable clinical outcomes in COVID-19 patients.年龄影响新冠病毒疾病（COVID-19）患者基于血细胞的免疫失调、抗体反应及不良临床结局。
Sci Rep. 2025 May 20;15(1):17431. doi: 10.1038/s41598-025-95722-3.
3
Clinical Impact of Neutrophil Variation on COVID-19 Complications.

本文引用的文献

1
Neutrophil-to-lymphocyte ratio as an independent risk factor for mortality in hospitalized patients with COVID-19.中性粒细胞与淋巴细胞比值可作为 COVID-19 住院患者死亡的独立危险因素。
J Infect. 2020 Jul;81(1):e6-e12. doi: 10.1016/j.jinf.2020.04.002. Epub 2020 Apr 10.
2
COVID-19 Does Not Lead to a "Typical" Acute Respiratory Distress Syndrome.新冠病毒肺炎不会导致“典型的”急性呼吸窘迫综合征。
Am J Respir Crit Care Med. 2020 May 15;201(10):1299-1300. doi: 10.1164/rccm.202003-0817LE.
3
Planning and provision of ECMO services for severe ARDS during the COVID-19 pandemic and other outbreaks of emerging infectious diseases.
中性粒细胞变化对新冠病毒疾病并发症的临床影响
Diagnostics (Basel). 2025 Feb 13;15(4):457. doi: 10.3390/diagnostics15040457.
4
Use of convalescent plasma in COVID-19 treatment: is clinical severity more important than the intervention?康复期血浆在新型冠状病毒肺炎治疗中的应用：临床严重程度是否比干预措施更重要？
Einstein (Sao Paulo). 2024 Dec 16;22:eAO0563. doi: 10.31744/einstein_journal/2024AO0563. eCollection 2024.
5
Neutrophil-to-Lymphocyte Ratio and Thrombocyte-to-Lymphocyte Ratio as a Predictor of Severe and Moderate/Mild Acute Respiratory Distress Syndrome Patients: Preliminary Results.中性粒细胞与淋巴细胞比值及血小板与淋巴细胞比值作为中重度/轻度急性呼吸窘迫综合征患者的预测指标：初步结果
J Crit Care Med (Targu Mures). 2024 Jan 30;10(1):49-55. doi: 10.2478/jccm-2024-0005. eCollection 2024 Jan.
6
TM9SF1 offers utility as an efficient predictor of clinical severity and mortality among acute respiratory distress syndrome patients.TM9SF1 可作为急性呼吸窘迫综合征患者临床严重程度和死亡率的有效预测因子。
Front Immunol. 2024 Jun 3;15:1408406. doi: 10.3389/fimmu.2024.1408406. eCollection 2024.
7
Unraveling the clinical significance and prognostic value of the neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, systemic immune-inflammation index, systemic inflammation response index, and delta neutrophil index: An extensive literature review.解读中性粒细胞与淋巴细胞比值、血小板与淋巴细胞比值、全身免疫炎症指数、全身炎症反应指数及中性粒细胞变化指数的临床意义和预后价值：一项广泛的文献综述
Turk J Emerg Med. 2024 Jan 8;24(1):8-19. doi: 10.4103/tjem.tjem_198_23. eCollection 2024 Jan-Mar.
8
First COVID-19 wave in the province of Bergamo, Italy: epidemiological and clinical characteristics, outcome and management of the first hospitalized patients.意大利贝加莫省的首次 COVID-19 疫情：首批住院患者的流行病学和临床特征、结局和治疗。
BMC Infect Dis. 2024 Jan 31;24(1):151. doi: 10.1186/s12879-024-09034-4.
9
Mortality in ICU COVID-19 Patients Is Associated with Neutrophil-to-Lymphocyte Ratio (NLR): Utility of NLR as a Promising Immunohematological Marker.重症监护病房中感染新型冠状病毒肺炎患者的死亡率与中性粒细胞与淋巴细胞比值（NLR）相关：NLR作为一种有前景的免疫血液学标志物的效用
Interdiscip Perspect Infect Dis. 2023 Nov 9;2023:9048749. doi: 10.1155/2023/9048749. eCollection 2023.
10
Neutrophil-to-Lymphocyte Ratio as a Predictor of Mortality for COVID-19-Related Acute Respiratory Distress Syndrome (ARDS) Patients Requiring Extracorporeal Membrane Oxygenation Therapy.中性粒细胞与淋巴细胞比值作为需要体外膜肺氧合治疗的 COVID-19 相关急性呼吸窘迫综合征（ARDS）患者死亡率的预测指标。
Cureus. 2023 Sep 29;15(9):e46238. doi: 10.7759/cureus.46238. eCollection 2023 Sep.
COVID-19 大流行期间和其他新发传染病疫情中严重急性呼吸窘迫综合征的体外膜肺氧合服务规划和供应。
Lancet Respir Med. 2020 May;8(5):518-526. doi: 10.1016/S2213-2600(20)30121-1. Epub 2020 Mar 20.
4
Preparing for COVID-19: early experience from an intensive care unit in Singapore.为应对新型冠状病毒肺炎做准备：新加坡一家重症监护病房的早期经验
Crit Care. 2020 Mar 9;24(1):83. doi: 10.1186/s13054-020-2814-x.
5
Acute respiratory distress syndrome: the Berlin Definition.急性呼吸窘迫综合征：柏林定义。
JAMA. 2012 Jun 20;307(23):2526-33. doi: 10.1001/jama.2012.5669.